DK0422154T3 - Terapeutisk anvendelse af 5-HT3-receptorantagonister - Google Patents

Terapeutisk anvendelse af 5-HT3-receptorantagonister

Info

Publication number
DK0422154T3
DK0422154T3 DK90905482.7T DK90905482T DK0422154T3 DK 0422154 T3 DK0422154 T3 DK 0422154T3 DK 90905482 T DK90905482 T DK 90905482T DK 0422154 T3 DK0422154 T3 DK 0422154T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
therapeutic use
disorders
agoraphobia
useful
Prior art date
Application number
DK90905482.7T
Other languages
Danish (da)
English (en)
Inventor
Alberto Azcona
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898909147A external-priority patent/GB8909147D0/en
Priority claimed from GB898916602A external-priority patent/GB8916602D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of DK0422154T3 publication Critical patent/DK0422154T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90905482.7T 1989-04-21 1990-04-06 Terapeutisk anvendelse af 5-HT3-receptorantagonister DK0422154T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898909147A GB8909147D0 (en) 1989-04-21 1989-04-21 Improvements in or relating to organic compounds
GB898916602A GB8916602D0 (en) 1989-07-20 1989-07-20 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
DK0422154T3 true DK0422154T3 (da) 1994-03-07

Family

ID=26295258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905482.7T DK0422154T3 (da) 1989-04-21 1990-04-06 Terapeutisk anvendelse af 5-HT3-receptorantagonister

Country Status (10)

Country Link
EP (1) EP0422154B1 (de)
JP (1) JPH0669963B2 (de)
KR (1) KR920700034A (de)
AT (1) ATE97803T1 (de)
AU (1) AU631632B2 (de)
CA (1) CA2031214A1 (de)
DE (1) DE69004924T2 (de)
DK (1) DK0422154T3 (de)
ES (1) ES2061024T3 (de)
WO (1) WO1990012569A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
US5508287A (en) * 1992-02-24 1996-04-16 Merrell Pharmaceuticals Inc. 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist
EP0641198A1 (de) * 1992-05-23 1995-03-08 Smithkline Beecham Plc Arzneimittel zur behandlung von angstzuständen
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US8563567B2 (en) 2009-12-30 2013-10-22 Arqule, Inc. Substituted heterocyclic compounds
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders
JP5387648B2 (ja) 2011-10-14 2014-01-15 株式会社デンソー 指針表示装置

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365296A (en) * 1970-10-30 1974-08-29 Unilever Ltd Dentifrice compositions
EP0099194A3 (de) * 1982-07-03 1984-04-11 Beecham Group Plc Benzamide
HU193592B (en) * 1984-01-25 1987-11-30 Glaxo Group Ltd Process for producing tetrahydro-carbazolone derivatives
DE3680123D1 (en) 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
EP0385517B1 (de) * 1985-03-14 1993-04-14 BEECHAM GROUP plc Arzneimittel zur Behandlung von Erbrechen
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
GB8518743D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518741D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Process
EP0212398A2 (de) 1985-08-21 1987-03-04 Siemens Aktiengesellschaft Verfahren zur Erkennung von Mehrfrequenzcodesignalen mit überlagerten Störsignalen
IL80707A (en) 1985-12-23 1991-03-10 Hughes Aircraft Co Gaseous discharge device simmering circuit
GB8701494D0 (en) 1987-01-23 1987-02-25 Glaxo Group Ltd Chemical compounds
DE3771376D1 (de) 1986-03-17 1991-08-22 Glaxo Group Ltd Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB8617994D0 (en) 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
DE3782107T2 (de) * 1986-07-25 1993-04-01 Beecham Group Plc Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
HU895334D0 (en) 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions
GB8623819D0 (en) 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
WO1988003801A1 (en) 1986-11-21 1988-06-02 Glaxo Group Limited Medicaments for treatment or prevention of withdrawal syndrome
GR871809B (en) 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
EP0272052B1 (de) * 1986-12-16 1992-07-08 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Angstlösende N-(1-Azabicyclo[2.2.2)oct-3-yl)benzamide und -thiobenzamide
GB8806990D0 (en) 1988-03-23 1988-04-27 Beecham Group Plc Novel compounds
DE3876006T2 (de) 1987-04-14 1993-03-25 Glaxo Group Ltd Keton-derivate.
DE3827253A1 (de) 1987-08-20 1989-03-02 Sandoz Ag Ester und amide von cyclischen carbonsaeuren und cyclischen alkoholen und aminen sowie verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
GB8720693D0 (en) 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
NZ226032A (en) 1987-09-03 1991-12-23 Glaxo Group Ltd 2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
JPH01258673A (ja) 1987-10-22 1989-10-16 Glaxo Group Ltd ケトン誘導体
DE3740984A1 (de) * 1987-12-03 1989-06-15 Sandoz Ag N-oxide von heterocyclischen carbonsaeurederivaten bzw. verfahren zu deren herstellung und deren verwendung
GB8802127D0 (en) 1988-02-01 1988-03-02 Glaxo Group Ltd Chemical compounds
EP0329904A1 (de) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Anxietas
DE68924545T2 (de) * 1988-02-23 1996-03-21 Merrell Dow Pharma Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.
US5116984A (en) 1988-04-07 1992-05-26 Glaxo Group Limited Imidazole derivatives
EP0339959A3 (de) 1988-04-27 1991-03-20 Glaxo Group Limited Laktam-Derivate
US4863921A (en) 1988-04-27 1989-09-05 Rorer Pharmaceutical Corporation Dibenzofurancarboxamides and their pharmaceutical compositions and methods
GB8812636D0 (en) 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
GB8814277D0 (en) 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JPH0669963B2 (ja) 1994-09-07
DE69004924T2 (de) 1994-05-19
CA2031214A1 (en) 1990-10-22
ES2061024T3 (es) 1994-12-01
EP0422154A1 (de) 1991-04-17
KR920700034A (ko) 1992-02-19
AU631632B2 (en) 1992-12-03
WO1990012569A1 (en) 1990-11-01
ATE97803T1 (de) 1993-12-15
AU5415890A (en) 1990-11-16
DE69004924D1 (de) 1994-01-13
JPH03505881A (ja) 1991-12-19
EP0422154B1 (de) 1993-12-01

Similar Documents

Publication Publication Date Title
PT804196E (pt) Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia
ATE300938T1 (de) Ulmwh (ultra-low-molecular weight heparin) zur behandlung von asthma
IT1232889B (it) Composizioni e procedimento per il trattamento ammorbidente di tessuti
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
BR9007938A (pt) Metodo e aparelho o tratamento de glaucoma
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69834693D1 (de) Zusammensetzung zur behandlung von elastischen polyurethanfasern und die damit behandelten fasern
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
FI963511L (fi) Pakko-oireisten häiriöiden hoito 5-HT2-antagonisteilla
DE69630321D1 (de) Vorrichtung zur örtlichen wärmebehandlung von gewebe
DK33487A (da) Midler til overfladebehandling, polymerer hertil og fremgangsmaade til overfladebehandling
DK0615751T3 (da) Anvendelse af tachykininantagonister til behandling af emesis
ATE234180T1 (de) Vorrichtung zum herstellen und gleichzeitigem verteilen von zementmischungen oder dergleichen
DE69524623D1 (de) Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
DE69013999D1 (de) Siliconkautschukzusammensetzung zur Behandlung von Faserstrukturen.
DE69716896D1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
ES2061024T3 (es) Uso terapeutico de antagonistas de receptores de 5-ht3.
FI971127A7 (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollagee nin kypsymis- ja rakentumishäiriöiden hoitamiseen
DE69721756D1 (de) Paroxetine zur behandlung von depression
ATA136490A (de) Behandlungsliege zur klangtherapie
DE69709287D1 (de) Mustererzeugungsverfahren und Oberflächenbehandlungsmittel
DE69717846D1 (de) Behandlungsverfahren von laktamen
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69001060D1 (de) Vorrichtung zur unterhaltung und reparatur von brueckendecken ohne verkehrsunterbrechung.
ATA29989A (de) Einrichtung zum feinblasigen belueften von abwasser